Application Information

This drug has been submitted to the FDA under the reference 019785/001.

Names and composition

"CARDIOLITE" is the commercial name of a drug composed of TECHNETIUM TC-99M SESTAMIBI KIT.

Answered questions

What is a Cardiolite Stress Test?

What is the the difference between a lexiscan stress test and a cardiolite stress test ?

WHAT CAN I EXPECT DURING THE CARDIOLITE NUCLEAR STRESS TEST? I AM A LITTLE APPREHENSIVE ABOUT THE PROCEDURE?

Why do doctors tell people that Cardiolite heart scans are equal to a chest x-ray when they are really 3 rem?

Question about Cardiolite?

Different test results on electrocardiogram and CardioLite?

Has anyone had a cardiolite stress test? I'm having one tomorrow morning & I'm slightly apprehensive?

In Cardiolite stress testing, why do doctors not exercise pts. with a LBBB and instead use lexi or abutomine?

I had a Cardiolite Stress Test using a chemical stressor showing "inferior Ischemia" and "fixed apical defect"

Has anyone ever had cardiolite reaction?

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
019785/001 CARDIOLITE TECHNETIUM TC-99M SESTAMIBI KIT INJECTABLE/INJECTION N per A

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
019785/001 CARDIOLITE TECHNETIUM TC-99M SESTAMIBI KIT INJECTABLE/INJECTION N per A
019785/003 MIRALUMA TECHNETIUM TC-99M SESTAMIBI KIT INJECTABLE/INJECTION N per A
078098/001 TECHNETIUM TC-99M SESTAMIBI TECHNETIUM TC-99M SESTAMIBI KIT INJECTABLE/INJECTION N per A
078806/001 TECHNETIUM TC 99M SESTAMIBI TECHNETIUM TC-99M SESTAMIBI KIT INJECTABLE/INJECTION N per A
078809/001 TECHNETIUM TC 99M SESTAMIBI TECHNETIUM TC-99M SESTAMIBI KIT INJECTABLE/INJECTION N per A
079157/001 TECHNETIUM TC 99M SESTAMIBI TECHNETIUM TC-99M SESTAMIBI KIT INJECTABLE/INJECTION 10-30mCi

Ask a question

A licenced doctor will try to answer your question as quickly as possible

* Mandatory fields

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved